Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice

Experimental Neurology

Volumn 205, Issue 2, 2007, Pages 425-436

  Vareniuk, Igor ^a   Pavlov, Ivan A ^a   Drel, Viktor R ^a   Lyzogubov, Valeriy V ^a   Ilnytska, Olga ^a   Bell, Seth R ^b   Tibrewala, Jyoti ^b   Groves, John T ^b   Obrosova, Irina G ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Intraepidermal nerve fiber loss; MNCV; Nitrosative stress; ob ob mouse; Peroxynitrite decomposition catalysts; SNCV; Tactile allodynia; Thermal hypoalgesia

Indexed keywords

3 NITROTYROSINE; IRON TETRAKIS(2 N TRIETHYLENE GLYCOL METHYL ETHER)PYRIDYL PORPHYRIN; IRON TETRAMESITYLPORPHYRIN OCTASULFONATE; LEPTIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERGLYCEMIA; HYPOALGESIA; IMMUNOFLUORESCENCE; MOTOR NERVE CONDUCTION; MOUSE; NERVE CONDUCTION DISORDER; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCIATIC NERVE; SENSORY NERVE CONDUCTION; SPINAL CORD; SPINAL GANGLION;

ANESTHESIA; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; LEPTIN; MICE; MICE, INBRED C57BL; MICE, OBESE; MOTOR NEURONS; NERVE FIBERS; NEURAL CONDUCTION; NEURONS, AFFERENT; NITRITES; PAIN; PAIN MEASUREMENT; PEROXYNITROUS ACID; POLY ADENOSINE DIPHOSPHATE RIBOSE; TOUCH;

EID: 34248560907     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.03.019     Document Type: Article

References (43)

1. Boulton A.J. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47 (2004) 1343-1353
2. Calcutt N.A., Freshwater J.D., Hauptmann N., Taylor E.M., and Mizisin A.P. Protection of sensory function in diabetic rats by Neotrofin. Eur. J. Pharmacol. 534 (2006) 187-193
3. Campestrini S., and Meunier B. Olefin epoxidation and alkane hydroxylation catalyzed by robust sulfonated manganese and iron porphyrins supported on cationic ion-exchange resins. Inorg. Chem. 31 (1992) 1999-2006
4. Cheng C., and Zochodne D.W. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52 (2003) 2363-2371
5. Christianson J.A., Riekhof J.T., and Wright D.E. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 179 (2003) 188-199
6. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., and Yorek M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50 (2001) 1927-1937
7. Diabetes in America, 1995. 2nd Edition. NIH Publication No. 95-1468. Bethesda, Maryland: National Institutes of Diabetes and Digestive and Kidney Diseases.
8. Drel V.R., Mashtalir N., Ilnytska O., Shin J., Li F., Lyzogubov V.V., and Obrosova I.G. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55 (2006) 3335-3343
9. Drel V.R., Pacher P., Stevens M.J., and Obrosova I.G. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic. Biol. Med. 40 (2006) 1454-1465
10. Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., Marton A., Hoyt D.G., Murthy K.G., Salzman A.L., Southan G.J., and Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med. 7 (2001) 108-113
11. Gibson T.M., Cotter M.A., and Cameron N.E. Effects of poly(ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats. Nitric Oxide 15 (2006) 344-350
12. +-ATPase activity. Am. J. Physiol.: Cell Physiol. 282 (2002) C560-C566
13. Ha H.C., Hester L.D., and Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3270-3275
14. Ho E.C.M., Lam K.S.L., Chen Y.S., Yip J.C.W., Arvindakshan M., Yamagishi S.-I., Yagihashi S., Oates P.J., Ellery C.A., Chung S.S.M., and Chung S.K. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55 (2006) 1946-1953
15. Hoeldtke R.D. Nitrosative stress in early Type 1 diabetes. David H. P. Streeten Memorial Lecture. Clin. Auton. Res. 13 (2003) 406-421
16. Ilnytska O., Lyzogubov V.V., Stevens M.J., Drel V.R., Mashtalir N., Pacher P., Yorek M.A., and Obrosova I.G. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55 (2006) 1686-1694
17. Jagtap P., and Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev., Drug Discov. 5 (2005) 421-440
18. Kamiya H., Murakawa Y., Zhang W., and Sima A.A. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes Metab. Res. Rev. 21 (2005) 448-458
19. Li F., Szabo C., Pacher P., Southan G.J., Abatan O.I., Charniauskaya T., Stevens M.J., and Obrosova I.G. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 47 (2004) 710-717
20. Mabley J.G., Liaudet L., Pacher P., Southan G.J., Groves J.T., Salzman A.L., and Szabo C. Part II. Beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol. Med. 10 (2002) 581-590
21. Malik R.A., Kallinikos P., Abbott C.A., van Schie C.H., Morgan P., Efron N., and Boulton A.J. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 46 (2003) 683-688
22. Malmberg A.B., Mizisin A.P., Calcutt N.A., von Stein T., Robbins W.R., and Bley K.R. Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111 (2004) 360-367
23. Minchenko A.G., Stevens M.J., White L., Abatan O.I., Komjati K., Pacher P., Szabo C., and Obrosova I.G. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J. 17 (2003) 1514-1516
24. Nangle M.R., Cotter M.A., and Cameron N.E. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur. J. Pharmacol. 502 (2004) 143-148
25. Obrosova I.G. Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep.3 (2003) 439-445
26. Obrosova I.G., Li F., Abatan O.I., Forsell M.A., Komjati K., Pacher P., Szabo C., and Stevens M.J. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53 (2004) 711-720
27. Obrosova I.G., Drel V.R., Pacher P., Ilnytska O., Wang Z.Q., Stevens M.J., and Yorek M.A. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54 (2005) 3435-3441
28. Obrosova I.G., Mabley J.G., Zsengeller Z., Charniauskaya T., Abatan O.I., Groves J.T., and Szabo C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 19 (2005) 401-403
29. Obrosova I.G., Pacher P., Szabo C., Zsengeller Z., Hirooka H., Stevens M.J., and Yorek M.A. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54 (2005) 234-242
30. Obrosova, I.G., Lyzogubov, V.V., Ilnytska, O., Mashtalir, N., Vareniuk, I., Pavlov, I., Xu, W., Zhang, J., Drel, V.R., in press. PARP inhibition or gene deficiency counteract intraepidermal nerve fiber loss and neuropathic pain associated with Type 1 diabetes. Diabetes [Abstract].
31. Oltman C.L., Coppey L.J., Gellett J.S., Davidson E.P., Lund D.D., and Yorek M.A. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am. J. Physiol.: Endocrinol. Metab. 289 (2005) E113-E122
32. Pacher P., Liaudet L., Soriano F.G., Mabley J.G., Szabo E., and Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51 (2002) 514-521
33. Pacher P., Liaudet L., Bai P., Mabley J.G., Kaminski P.M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M.S., Groves J.T., and Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107 (2003) 896-904
34. Pacher P., Obrosova I.G., Mabley J.G., and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr. Med. Chem. 12 (2005) 267-275
35. Pavlov, I., Vareniuk, I., Drel, V.R., Lyzogubov, V.V., Ilnytska, O., Mashtalir, N., Tibrewala, J., Groves, J.T., Obrosova, I.G., in press. Nitrosative stress and neuropathy in mouse models of Type 1 and Type 2 diabetes. Diabetes [Abstract].
36. Pittenger G., Burkus N., McNulty P., Basta B., and Vinik A. Intraepidermal nerve fibers are indicators of small fiber neuropathy in both diabetic and non-diabetic patients. Diabetes Care 27 (2004) 1974-1979
37. Shimanovich R., and Groves J.T. Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 387 (2001) 307-317
38. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., and Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60 (2003) 108-111
39. Szabo C., Mabley J.G., Moeller S.M., Shimanovich R., Pacher P., Virag L., Soriano F.G., Van Duzer J.H., Williams W., Salzman A.L., and Groves J.T. Part I. Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 10 (2002) 571-580
40. Szabo C., Biser A., Benko R., Bottinger E., and Susztak K. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 55 (2006) 3004-3012
41. Szenczi O., Kemecsei P., Holthuijsen M.F., van Riel N.A., van der Vusse G.J., Pacher P., Szabo C., Kollai M., Ligeti L., and Ivanics T. Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem. Pharmacol. 69 (2005) 725-732
42. Veres B., Radnai B., Gallyas F.Jr., Varbiro G., Berente Z., Osz E., and Sumegi B. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J. Pharmacol. Exp. Ther. 310 (2004) 247-255
43. Zheng L., Szabo C., and Kern T.S. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53 (2004) 2960-2967